BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1904395)

  • 1. G protein Gs alpha (GNAS 1), the probable candidate gene for Albright hereditary osteodystrophy, is assigned to human chromosome 20q12-q13.2.
    Rao VV; Schnittger S; Hansmann I
    Genomics; 1991 May; 10(1):257-61. PubMed ID: 1904395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy.
    Ringel MD; Schwindinger WF; Levine MA
    Medicine (Baltimore); 1996 Jul; 75(4):171-84. PubMed ID: 8699958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A disruptive mutation in exon 3 of the GNAS gene with albright hereditary osteodystrophy, normocalcemic pseudohypoparathyroidism, and selective long transcript variant Gsalpha-L deficiency.
    Thiele S; Werner R; Ahrens W; Hoppe U; Marschke C; Staedt P; Hiort O
    J Clin Endocrinol Metab; 2007 May; 92(5):1764-8. PubMed ID: 17299070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism.
    De Sanctis L; Romagnolo D; Olivero M; Buzi F; Maghnie M; Scirè G; Crino A; Baroncelli GI; Salerno M; Di Maio S; Cappa M; Grosso S; Rigon F; Lala R; De Sanctis C; Dianzani I
    Pediatr Res; 2003 May; 53(5):749-55. PubMed ID: 12621129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of signal-transducing G proteins in human disease.
    Schnabel P; Böhm M
    J Mol Med (Berl); 1995 May; 73(5):221-8. PubMed ID: 7670925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albright's hereditary osteodystrophy (pseudohypoparathyroidism type Ia): clinical case with a novel mutation of GNAS1.
    Garavelli L; Pedori S; Zanacca C; Caselli G; Loiodice A; Mantovani G; Ammenti A; Virdis R; Banchini G
    Acta Biomed; 2005 Apr; 76(1):45-8. PubMed ID: 16116826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of two novel deletion mutations within the Gs alpha gene (GNAS1) in Albright hereditary osteodystrophy.
    Yu D; Yu S; Schuster V; Kruse K; Clericuzio CL; Weinstein LS
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3254-9. PubMed ID: 10487696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective deficiency of Gsalpha and the possible role of alternative gene products of GNAS in Albright hereditary osteodystrophy and pseudohypoparathyroidism type Ia.
    Thiele S; Werner R; Ahrens W; Hübner A; Hinkel KG; Höppner W; Igl B; Hiort O
    Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):127-32. PubMed ID: 19658058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G protein mutations in human disease.
    Weinstein LS; Shenker A
    Clin Biochem; 1993 Oct; 26(5):333-8. PubMed ID: 8299203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a de novo 43-bp deletion of the Gs alpha gene (GNAS1) in Albright hereditary osteodystrophy.
    Luttikhuis ME; Wilson LC; Leonard JV; Trembath RC
    Genomics; 1994 May; 21(2):455-7. PubMed ID: 8088846
    [No Abstract]   [Full Text] [Related]  

  • 11. [Albright hereditary osteodystrophy: identification of a novel mutation in a family].
    Bastida Eizaguirre M; Iturbe Ortiz De Urbina R; Arto Urzainqui M; Ezquerra Larreina R; Escalada San Martín J
    An Esp Pediatr; 2001 Jun; 54(6):598-600. PubMed ID: 11412411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic deficiency of the alpha subunit of the guanine nucleotide-binding protein Gs as the molecular basis for Albright hereditary osteodystrophy.
    Levine MA; Ahn TG; Klupt SF; Kaufman KD; Smallwood PM; Bourne HR; Sullivan KA; Van Dop C
    Proc Natl Acad Sci U S A; 1988 Jan; 85(2):617-21. PubMed ID: 2829196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique skin changes in a case of Albright hereditary osteodystrophy caused by a rare GNAS1 mutation.
    Klaassens M; Blom EW; Schrander JJ; Ris-Stalpers C; Nieuwenhuijzen Kruseman AC; van Steensel MA; Schrander-Stumpel CT
    Br J Dermatol; 2010 Mar; 162(3):690-4. PubMed ID: 19863504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudohypoparathyroidism type Ia. Albright hereditary osteodystrophy: a model for research on G protein-coupled receptors and genomic imprinting.
    Simon A; Koppeschaar HP; Roijers JF; Höppener JW; Lips CJ
    Neth J Med; 2000 Mar; 56(3):100-9. PubMed ID: 10759021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parental origin of Gs alpha gene mutations in Albright's hereditary osteodystrophy.
    Wilson LC; Oude Luttikhuis ME; Clayton PT; Fraser WD; Trembath RC
    J Med Genet; 1994 Nov; 31(11):835-9. PubMed ID: 7853365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of disorders caused by defects in G proteins.
    Spiegel AM
    Horm Res; 1997; 47(3):89-96. PubMed ID: 9050946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A heterozygous 4-bp deletion mutation in the Gs alpha gene (GNAS1) in a patient with Albright hereditary osteodystrophy.
    Weinstein LS; Gejman PV; de Mazancourt P; American N; Spiegel AM
    Genomics; 1992 Aug; 13(4):1319-21. PubMed ID: 1505964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gs(alpha) mutations and imprinting defects in human disease.
    Weinstein LS; Chen M; Liu J
    Ann N Y Acad Sci; 2002 Jun; 968():173-97. PubMed ID: 12119276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients.
    Mantovani G; de Sanctis L; Barbieri AM; Elli FM; Bollati V; Vaira V; Labarile P; Bondioni S; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2010 Feb; 95(2):651-8. PubMed ID: 20061437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance.
    Mariot V; Maupetit-Méhouas S; Sinding C; Kottler ML; Linglart A
    J Clin Endocrinol Metab; 2008 Mar; 93(3):661-5. PubMed ID: 18182455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.